Alwar Ramanujam Padmavathi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alwar Ramanujam Padmavathi has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Shunmugiah Karutha Pandian
Department of Biotechnology Alagappa University Karaikudi India
6 shared publications - P. Sriyutha Murthy
Water & Steam Chemistry Division, Bhabha Atomic Research Centre
5 shared publications - Dhamodharan Bakkiyaraj
Bharathidasan University
4 shared publications - Teerapol Srichana
Drug Delivery System Excellence Center, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand
3 shared publications Toleti Subba Rao
3 shared publicationsArindam Das
2 shared publications
Latest Publications
- 14 January 2026
- Published by Elsevier in Trends in Microbiology
- Vol. 34 (2) , 119-122
Scientific mobility in microbiology – 12
- 14 January 2026
- Published by Elsevier in Trends in Microbiology
- Vol. 34 (2) , 119-122
Scientific mobility in microbiology – 12
- Open Access
- 13 November 2025
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 14 (11) , e0088525
Complete genome sequence of copper-tolerant Mammaliicoccus lentus strain BARC
We report the complete genome sequence of Mammaliicoccus lentus strain BARC, a copper-tolerant, biofilm-forming bacterium isolated from marine biofilms formed on titanium coupons exposed to the Bay of Bengal. The genome consisted of a single circular contig of 2.9 Mb with 31.89% GC content, 2,988 genes, including 2,623 coding sequences.
- 13 November 2025
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 14 (11) , e0088525
Open AccessComplete genome sequence of copper-tolerant Mammaliicoccus lentus strain BARC
We report the complete genome sequence of Mammaliicoccus lentus strain BARC, a copper-tolerant, biofilm-forming bacterium isolated from marine biofilms formed on titanium coupons exposed to the Bay of Bengal. The genome consisted of a single circular contig of 2.9 Mb with 31.89% GC content, 2,988 genes, including 2,623 coding sequences.
- 15 September 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1711-1730
Computational Identification of Inhibitors Targeting Hercynylcysteine Sulfoxide Lyase of Mycobacterium tuberculosis : Structure-Guided Virtual Screening and Molecular Dynamics Simulation Studies
Tuberculosis (TB) is a contagious airborne disease characterized by an increasing incidence of multidrug resistance. TB is a leading cause of bacterial infection-related deaths worldwide. Since the available drugs are not effective and the drug targets are acquiring resistance, there is a necessity to discover new and promising drug targets and lead molecules to combat drug-resistant TB. In this context, our study explored the possibility of utilizing hercynylcysteine sulfoxide lyase, which is one of the major redox systems that prevents bacteria from maintaining redox homeostasis. However, the complete mechanism of Mtb redox homeostasis remains unknown; hence, we constructed a model of the target protein to understand its structural features and probable mechanisms. MD simulations were conducted for 100 ns to examine the structural characteristics and structural integrity of the modeled three-dimensional protein structure. Furthermore, we identified three potent plant phytochemicals using a structure-guided virtual-screening strategy. The identified phytochemicals (CID: 137, 119 and 449468) were nontoxic and showed stable binding in MMGBSA and molecular dynamics simulation analysis. Overall, our results indicate that these three phytochemicals could bind to the functional site of hercynylcysteine sulfoxide lyase to impede its biological function, and further experimental validation is needed to validate our computational findings.
- 15 September 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1711-1730
Computational Identification of Inhibitors Targeting Hercynylcysteine Sulfoxide Lyase of Mycobacterium tuberculosis : Structure-Guided Virtual Screening and Molecular Dynamics Simulation Studies
Tuberculosis (TB) is a contagious airborne disease characterized by an increasing incidence of multidrug resistance. TB is a leading cause of bacterial infection-related deaths worldwide. Since the available drugs are not effective and the drug targets are acquiring resistance, there is a necessity to discover new and promising drug targets and lead molecules to combat drug-resistant TB. In this context, our study explored the possibility of utilizing hercynylcysteine sulfoxide lyase, which is one of the major redox systems that prevents bacteria from maintaining redox homeostasis. However, the complete mechanism of Mtb redox homeostasis remains unknown; hence, we constructed a model of the target protein to understand its structural features and probable mechanisms. MD simulations were conducted for 100 ns to examine the structural characteristics and structural integrity of the modeled three-dimensional protein structure. Furthermore, we identified three potent plant phytochemicals using a structure-guided virtual-screening strategy. The identified phytochemicals (CID: 137, 119 and 449468) were nontoxic and showed stable binding in MMGBSA and molecular dynamics simulation analysis. Overall, our results indicate that these three phytochemicals could bind to the functional site of hercynylcysteine sulfoxide lyase to impede its biological function, and further experimental validation is needed to validate our computational findings.
- Open Access
- 1 April 2025
- Published by Elsevier in Results in Surfaces and Interfaces
- Vol. 19
Facile fabrication of self-assembled monolayers of organosilanes for antibiofilm applications
- 1 April 2025
- Published by Elsevier in Results in Surfaces and Interfaces
- Vol. 19
Open AccessFacile fabrication of self-assembled monolayers of organosilanes for antibiofilm applications
- 5 January 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 200, 107282
Polydimethylsiloxane loaded capsaicin afflicts membrane integrity, metabolic activity and biofilm formation of nosocomial pathogens
- 5 January 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 200, 107282
Polydimethylsiloxane loaded capsaicin afflicts membrane integrity, metabolic activity and biofilm formation of nosocomial pathogens
- 16 July 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 194, 106800
New arsenals for old armour: Biogenic nanoparticles in the battle against drug-resistant Candida albicans
- 16 July 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 194, 106800
New arsenals for old armour: Biogenic nanoparticles in the battle against drug-resistant Candida albicans
- 27 September 2023
- Published by Bentham Science Publishers Ltd.
- p. 389-408
Recent Update on the Patents of Antimicrobial Marine Natural Products
Marine environment has long been shown as the source of diverse organisms and niche for numerous bioactive agents. Marine natural products are of recent interest attributing to their novelty and abundant potential in the field of medicine as well as others. In spite of this recent attention, the marine environment still exists as an under-explored and untapped resource for bioactive agents, highlighting the presence of plentiful opportunities. Bioactive molecules of marine origin have been frequently reported from the microorganisms associated with marine sediments, seawater, coral and its mucus; higher-order marine organisms, mangroves, sponges, seaweeds and sea grasses, etc. Last decade has shown copious publications reporting the bioactive potentials of marine natural products such as antimicrobial, antiviral, antiparasitic, anticancer, antioxidant, anti-inflammatory and anti-infective properties. Recent studies have also opened an avenue in marine natural product research where the discovered natural products are chemically modified to attain increased bioactivity. Such modified or altered marine natural products were of great demand in pharmaceutical, food, cosmetic and chemical industries, and hence protected by product and process patents. This chapter summarizes the intellectual property rights in the form of patents protecting marine natural products with antimicrobial potentials, including antibacterial, antifungal and antibiofilm activities. This chapter also highlights the patents and applications of modified or semi-synthetic agents related to marine natural sources with antimicrobial properties.
- 27 September 2023
- Published by Bentham Science Publishers Ltd.
- p. 389-408
Recent Update on the Patents of Antimicrobial Marine Natural Products
Marine environment has long been shown as the source of diverse organisms and niche for numerous bioactive agents. Marine natural products are of recent interest attributing to their novelty and abundant potential in the field of medicine as well as others. In spite of this recent attention, the marine environment still exists as an under-explored and untapped resource for bioactive agents, highlighting the presence of plentiful opportunities. Bioactive molecules of marine origin have been frequently reported from the microorganisms associated with marine sediments, seawater, coral and its mucus; higher-order marine organisms, mangroves, sponges, seaweeds and sea grasses, etc. Last decade has shown copious publications reporting the bioactive potentials of marine natural products such as antimicrobial, antiviral, antiparasitic, anticancer, antioxidant, anti-inflammatory and anti-infective properties. Recent studies have also opened an avenue in marine natural product research where the discovered natural products are chemically modified to attain increased bioactivity. Such modified or altered marine natural products were of great demand in pharmaceutical, food, cosmetic and chemical industries, and hence protected by product and process patents. This chapter summarizes the intellectual property rights in the form of patents protecting marine natural products with antimicrobial potentials, including antibacterial, antifungal and antibiofilm activities. This chapter also highlights the patents and applications of modified or semi-synthetic agents related to marine natural sources with antimicrobial properties.
- 1 August 2021
- Published by Elsevier in Surfaces and Interfaces
- Vol. 25
Inorganic nanoparticle embedded Polydimethyl siloxane nanocomposites for biofouling mitigation
- 1 August 2021
- Published by Elsevier in Surfaces and Interfaces
- Vol. 25
Inorganic nanoparticle embedded Polydimethyl siloxane nanocomposites for biofouling mitigation
- 1 June 2020
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 17 (3) , 271-279
In Vitro Studies of Jatropha curcas L. Latex Spray Formulation for Wound Healing Applications
There is an increasing demand for wound healing products of natural origin. Our objective was to develop a spray formulation from Jatropha curcas (J. curcas) L. latex extracts for wound healing applications. J. curcas L. latex was subjected to solvent extraction. The phytochemical structure was elucidated by 1H-NMR and confirmed by liquid chromatography-mass spectrometer spectrometry. A topical spray formulation prepared from J. curcas latex extracts was evaluated in terms of its antimicrobial activity and radical scavenging activity. The toxicity of the formulation on fibroblast cell lines, collagen production, and wound healing activities were tested. The 1H-NMR and mass spectrometric analyses revealed the pure compound as curcacycline A. The J. curcas latex extract formulation had radical scavenging and antibacterial activities. Moreover, the formulation was not toxic to the human fibroblast cells and it stimulated collagen production and healed cell injury in 24 h. The J. curcas latex extract promoted wound healing after cell injury. Our findings indicate the possibility of utilizing the J. curcas latex extract spray formulation as a potential antibacterial, antioxidant, and wound healing product from nature.
- 1 June 2020
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 17 (3) , 271-279
In Vitro Studies of Jatropha curcas L. Latex Spray Formulation for Wound Healing Applications
There is an increasing demand for wound healing products of natural origin. Our objective was to develop a spray formulation from Jatropha curcas (J. curcas) L. latex extracts for wound healing applications. J. curcas L. latex was subjected to solvent extraction. The phytochemical structure was elucidated by 1H-NMR and confirmed by liquid chromatography-mass spectrometer spectrometry. A topical spray formulation prepared from J. curcas latex extracts was evaluated in terms of its antimicrobial activity and radical scavenging activity. The toxicity of the formulation on fibroblast cell lines, collagen production, and wound healing activities were tested. The 1H-NMR and mass spectrometric analyses revealed the pure compound as curcacycline A. The J. curcas latex extract formulation had radical scavenging and antibacterial activities. Moreover, the formulation was not toxic to the human fibroblast cells and it stimulated collagen production and healed cell injury in 24 h. The J. curcas latex extract promoted wound healing after cell injury. Our findings indicate the possibility of utilizing the J. curcas latex extract spray formulation as a potential antibacterial, antioxidant, and wound healing product from nature.